Table 5.
Significant Symptomatic and Psychological Functioning Differences Between Dependent and Nondependent Users at Baseline and Post-Treatment
| Baseline | Post-treatment | |||||
|---|---|---|---|---|---|---|
| Dependent users | Nondependent users | p | Dependent users | Nondependent users | p | |
| BDI | 4 [0–14] | 0.5 [0–2] | 0.004a | 1 [0–9] | 0 [0–12] | 0.47 |
| CAPE | ||||||
| Total freq | 62.67 (10.95) | 54.13 (6.73) | 0.045a | 56.67 (10.04) | 55.00 (45–69) | 0.69 |
| Neg freq | 24.50 (4.81) | 20.62 (2.83) | 0.036a | 21.25 (5.29) | 22.13 (4.19) | 0.70 |
| GAF | 77.75 (7.71) | 86.25 (6.41) | 0.019a | 79.08 (8.32) | 87.50 (6.55) | 0.027a |
| SOFAS | 77.50 (8.92) | 87.25 (4.20) | 0.010a | 79.67 (9.90) | 87.75 (5.90) | 0.053 |
Mean (SD) or median [range].
a
Significant between-group differences for dependent versus nondependent cannabis users at baseline and post-treatment.
CAPE Total Freq, CAPE total symptom frequency scores; CAPE Neg Freq; CAPE negative symptom frequency scores; Dependent, dependent cannabis-user group (defined as ≥3 on the SDS at baseline); Nondependent, nondependent cannabis user group (defined at <3 on the SDS at baseline).